99 related articles for article (PubMed ID: 1405256)
1. [Cardiolipin antibodies in patients with myocardial infarction and unstable angina pectoris].
Nasonov EL; Noeva EA; Kovalev VIu; Dragnev AG; Lopaeva OV; Ruda MIa
Kardiologiia; 1992 May; 32(5):32-4. PubMed ID: 1405256
[TBL] [Abstract][Full Text] [Related]
2. Measuring of cardiolipin antibodies and plasma lipids in different stages of coronary disease.
Rebić R; Nastić-Mirić D; Pavlović S; Pokrajcić Z; Bosnjaković V
Med Pregl; 1993; 46 Suppl 1():20-2. PubMed ID: 8569595
[TBL] [Abstract][Full Text] [Related]
3. Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome.
Gürlek A; Ozdöl C; Pamir G; Dinçer I; Tutkak H; Oral D
Int Heart J; 2005 Jul; 46(4):631-8. PubMed ID: 16157954
[TBL] [Abstract][Full Text] [Related]
4. [Immunological characteristics of patients with acute coronary syndrome (unstable angina and myocardial infarction)].
Logacheva IV; Leshchinskiĭ LA; Zvorygin IA
Klin Med (Mosk); 1999; 77(4):23-5. PubMed ID: 10356912
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction.
Wu R; Nityanand S; Berglund L; Lithell H; Holm G; Lefvert AK
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3159-63. PubMed ID: 9409306
[TBL] [Abstract][Full Text] [Related]
6. Anticardiolipin antibodies in patients with unstable angina.
Diaz MN; Becker RC
Cardiology; 1994; 84(6):380-4. PubMed ID: 8062302
[No Abstract] [Full Text] [Related]
7. Effect of phase I periodontal therapy on anti-cardiolipin antibodies in patients with acute myocardial infarction associated with chronic periodontitis.
Gunupati S; Chava VK; Krishna BP
J Periodontol; 2011 Dec; 82(12):1657-64. PubMed ID: 21486181
[TBL] [Abstract][Full Text] [Related]
8. Importance of serum anticardiolipin antibody levels in coronary heart disease.
Yilmaz E; Adalet K; Yilmaz G; Badur S; Erzengin F; Koylan N; Ozsaruhan O; Ertem G; Büyüköztürk K
Clin Cardiol; 1994 Mar; 17(3):117-21. PubMed ID: 8168279
[TBL] [Abstract][Full Text] [Related]
9. Influence of anticardiolipin antibodies on immediate patient outcome after myocardial infarction.
Raghavan C; Ditchfield J; Taylor RJ; Haeney MR; Barnes PC
J Clin Pathol; 1993 Dec; 46(12):1113-5. PubMed ID: 8282835
[TBL] [Abstract][Full Text] [Related]
10. [Chlamydia antibody titers in patients with coronary disease: relations to age and clinical stage].
el-Rabadi K; Gottsauner-Wolf M; Christ G; Maurer G; Huber K
Wien Klin Wochenschr; 2001 Oct; 113(19):727-30. PubMed ID: 11715750
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies in young myocardial infarction patients.
Mishra MN; Kalra R; Gupta MK
Indian J Biochem Biophys; 2007 Dec; 44(6):481-4. PubMed ID: 18320848
[TBL] [Abstract][Full Text] [Related]
12. Relation between left ventricular and/or left atrial thrombus and anticardiolipin antibodies in patients with acute myocardial infarction.
Güler N; Bilge M; Eryonucu B; Erkoç R; Sayarlioğlu M
Am J Cardiol; 2000 Jun; 85(11):1391-3. PubMed ID: 10831965
[No Abstract] [Full Text] [Related]
13. [Connections between ischemic heart disease and anti-cardiolipin antibody positivity].
Ferlazzo B; Bonanno D; Quattrocchi P; Paino AM; Arrigo F
Minerva Cardioangiol; 1993 Apr; 41(4):113-7. PubMed ID: 8332265
[TBL] [Abstract][Full Text] [Related]
14. [Anticardiolipin antibodies and early infarct of the myocardium].
Gaeta G; Lupoli S; Brancaccio V; Effuso L; Russo V; Boccalatte A
Cardiologia; 1998 Jul; 43(7):731-5. PubMed ID: 9738331
[TBL] [Abstract][Full Text] [Related]
15. Association of serum C3 levels with the risk of myocardial infarction.
Muscari A; Bozzoli C; Puddu GM; Sangiorgi Z; Dormi A; Rovinetti C; Descovich GC; Puddu P
Am J Med; 1995 Apr; 98(4):357-64. PubMed ID: 7709948
[TBL] [Abstract][Full Text] [Related]
16. Anticardiolipin antibodies in ischaemic heart disease: marker or myth?
Phadke KV; Phillips RA; Clarke DT; Jones M; Naish P; Carson P
Br Heart J; 1993 May; 69(5):391-4. PubMed ID: 8518060
[TBL] [Abstract][Full Text] [Related]
17. Study of anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with ischemic stroke.
Cojocaru IM; Cojocaru M; Muşuroi C; Botezat M
Rom J Intern Med; 2003; 41(2):189-204. PubMed ID: 15526503
[TBL] [Abstract][Full Text] [Related]
18. Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythmatosus patients: a controlled prospective study.
Zuckerman E; Toubi E; Shiran A; Sabo E; Shmuel Z; Golan TD; Abinader E; Yeshurun D
Am J Med; 1996 Oct; 101(4):381-6. PubMed ID: 8873508
[TBL] [Abstract][Full Text] [Related]
19. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
[TBL] [Abstract][Full Text] [Related]
20. Increase of chlamydial LPS antibodies in patients with acute coronary syndrome without detection of chlamydial DNA in atherectomy samples.
Kiss K; Khanakah G; Kundi M; Glogar HD; Stanek G
Wien Klin Wochenschr; 2001 Oct; 113(19):731-6. PubMed ID: 11715751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
